Samsung Biologics revenue and financials
₩1,277,000.00Change from previous close: −2.52%Absolute change: −₩33,000.00
In the fiscal year ended December 2025, Samsung Biologics reported revenue of ₩4.56T (+30.31% year over year). Net income was ₩1.78T, a net margin of 39.2%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +30.31%
- 2025 vs 2024
- Net income growth
- +64.71%
- 2025 vs 2024
- Net margin
- 39.2%
- 2024: 31.0%
Financial data
Amounts in millions of KRW; per-share values in KRW; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 624,805 | 767,683 | 619,296 | 523,379 | 682,981 | 740,392 | 239,461 | 289,843 | 832,859 | 291,409 | 225,229 | 316,731 |
| Depreciation and amortization | 112,078 | 94,559 | 178,919 | 178,197 | 163,401 | 156,822 | 148,046 | 143,416 | 141,945 | 138,525 | 108,635 | 100,677 |
| Capital expenditure | -87,431 | -85,180 | -93,161 | -134,624 | -624,147 | -549,311 | -104,091 | -78,447 | -271,757 | -135,061 | -159,073 | -429,179 |
| Investing cash flow | -913,069 | -400,305 | -213,704 | -540,288 | -250,222 | -437,122 | -317,007 | 584,917 | -449,755 | -372,320 | -1,134,693 | 390,462 |
| Financing cash flow | 39,652 | -2,216 | -202,254 | -2,624 | -69,803 | -713,370 | -32,479 | -202,289 | -285,513 | -179,365 | -84,369 | -85,803 |
| Share repurchases | — | — | — | — | — | — | — | — | -200 | — | — | — |
| Debt issued | 44,453 | — | 40,000 | 0.0 | 45,000 | 140,000 | 50,000 | 30,000 | 376,500 | 260,000 | 59,000 | 108,000 |
| Debt repaid | -4,801 | -2,216 | -242,254 | -2,624 | -114,803 | -853,370 | -82,479 | -232,289 | -662,013 | -439,445 | -143,369 | -193,923 |
| Effect of exchange rates | 16,825 | 6,350 | 9,311 | -23,048 | -2,118 | -23,183 | 23,453 | 19,673 | -8,840 | 4,644 | 6,457 | 9,983 |
| Net change in cash | -231,787 | 371,512 | 212,649 | -42,581 | 360,838 | -433,283 | -86,571 | 692,144 | 88,752 | -255,632 | -987,375 | 631,373 |
| Free cash flow | 537,374 | 682,503 | 526,135 | 388,754 | 58,834 | 191,081 | 135,371 | 211,396 | 561,102 | 156,348 | 66,156 | -112,449 |
| Levered free cash flow | 433,280 | 464,540 | 333,740 | 254,929 | -136,842 | -12,123 | -562,619 | 660,618 | 419,152 | 8,821 | -420,014 | -454,612 |